EIH has released its annual results for the year ended 31 December 2013. These are somewhat out of date now but show the net asset value rising from 72.7 cents to 74.7 cents per share – an increase of 2.8%. EIH also distributed 2 cents per share during the year.
The company’s holding in Gland Pharma is being sold; EIH expect to receive $19.5m – 2.85x cost.